Imaging and quantitation of the hypoxic cell fraction of viable tumor in an animal model of intracerebral high grade glioma using [18F]fluoromisonidazole (FMISO)
- 28 February 2002
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 29 (2) , 191-197
- https://doi.org/10.1016/s0969-8051(01)00298-0
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- No evidence of hypoxic tissue on 18 F-fluoromisonidazole PET after intracerebral hemorrhageNeurology, 1999
- A modeling approach for quantifying tumor hypoxia with [F‐18]fluoromisonidazole PET time‐activity dataMedical Physics, 1995
- Rapid Synthesis of 3-[18F]Fluoro-l-(2′-Nitro-1′-Imidazolyl)-2-Propanol ([18F]Fluoromisonidazole)Pharmaceutical Research, 1994
- Hypoxia and local tumour control. Part 2Radiotherapy and Oncology, 1991
- No-carrier-added synthesis of 3-[18F]fluoro-1-(2-nitro-1-imidazolyl)-2-propanol. A potential PET agent for detecting hypoxic but viable tissuesApplied Radiation and Isotopes, 1989
- Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1988
- A new glioma model in rat: The C6 spheroid implantation technique permeability and vascular characterizationJournal of Neuro-Oncology, 1987
- Glucose utilization of cerebral gliomas measured by [ 18 F] fluorodeoxyglucose and positron emission tomographyNeurology, 1982
- Hypoxic Sensitizers — Implications for Radiation TherapyNew England Journal of Medicine, 1979
- The Concentration of Oxygen Dissolved in Tissues at the Time of Irradiation as a Factor in RadiotherapyThe British Journal of Radiology, 1953